Document Type

Article

Department

General Surgery (East Africa); Internal Medicine (East Africa)

Abstract

Background: Incidental prostate cancer is detected by histological examination of resected biopsy tissue that has been previously diagnosed as benign. It has the potential for progressing to become a disease necessitating active treatment. There is paucity of data on detection of incidental prostate cancer in Tanzania. A study done in northern Tanzania among the urban public sector revealed an alarming detection rate of 21.71%. We aimed to establish the prevalence of incidental prostate cancer among men surgically treated for benign prostate enlargement with considered normal range of prostate specific antigen.

Methods: This was a retrospective hospital-based cross-sectional study conducted to establish the prevalence of incidental prostate cancer among men who underwent transurethral resection of prostate with considered normal range of prostate-specific antigen from 2010 to 2019 at Aga Khan Hospital Dar es salaam, Tanzania. To find the prevalence of incidental prostate cancer with 95% confidence level, 5% tolerable error, minimum of 195 participants’ data was reviewed, and factors associated with incidental prostate carcinoma were evaluated by binary regression analysis.

Results: Total of 195 men were included in the study. The prevalence of incidental prostate cancer among men with prostate-specific antigen levels of less than 5.5ng/mL was 7.2% (95% CI, 4.0 to 11.8%). More than half of the patients had high-grade cancer and three-quarters had T1b histological subtype making up the clinically significant category. For every 1-year increase in age from age of 65 years, the risk of incidental prostate cancer increased by 1.6 (95% CI, 1.054 to 23.38; P

Conclusion: The Incidental prostate cancer detection rate of 7.2% in our settings is within the range found internationally.

Publication (Name of Journal)

Tanzania Medical Journal

DOI

https://doi.org/10.4314/tmj.v32i4.417

Creative Commons License

Creative Commons Attribution-Share Alike 4.0 International License
This work is licensed under a Creative Commons Attribution-Share Alike 4.0 International License.

Share

COinS